India to Mexico: Imipenem Export Trade Route

The India to Mexico Imipenem corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $9.1M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's imipenem manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $412.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with imipenem's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 13.9%, placing it at rank #4 among India's top imipenem export destinations globally.

On the import side, key buyers of Indian imipenem in Mexico include LABORATORIOS JAYOR S.A. DE C.V. , LABORATORIOS JAYOR S A DE C V, L J S.A DE CV and 4 others. LABORATORIOS JAYOR S.A. DE C.V. is the single largest importer with 8 shipments valued at $3.6M USD.

India's imipenem exports to Mexico are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $412.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as sensimitina 500mg (imipenem / cilastatin and imipenem and cilastatin 500mg (imipenem/cilastatin 500mg/500mg solution for injection), suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIOS JAYOR S.A. DE C.V. is the largest importer with 8 shipments worth $3.6M USD — representing 40% of all imipenem imports from India on this route. A total of 7 buyers are active on this corridor.